Gilead Sciences Total Current Assets increased by 2.6% to $18.34B in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 4.3%, from $19.17B to $18.34B. Over 5 years (FY 2020 to FY 2025), Total Current Assets shows an upward trend with a 2.8% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
A higher value relative to current liabilities indicates a strong safety margin for meeting short-term obligations.
The sum of all assets that are reasonably expected to be converted into cash or consumed within one year. This aggregate...
High-growth tech companies often maintain high current asset levels to support rapid scaling and R&D needs.
total_current_assets| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $13.93B | $13.99B | $14.77B | $12.63B | $13.18B | $13.55B | $14.44B | $13.46B | $14.29B | $15.98B | $16.09B | $14.04B | $12.32B | $14.78B | $19.17B | $16.90B | $14.72B | $17.87B | $18.34B |
| QoQ Change | — | +0.5% | +5.6% | -14.5% | +4.3% | +2.9% | +6.6% | -6.8% | +6.2% | +11.8% | +0.7% | -12.7% | -12.3% | +20.0% | +29.7% | -11.8% | -12.9% | +21.4% | +2.6% |
| YoY Change | — | — | — | — | -5.4% | -3.1% | -2.2% | +6.5% | +8.4% | +17.9% | +11.4% | +4.3% | -13.8% | -7.5% | +19.2% | +20.4% | +19.5% | +20.9% | -4.3% |
We use cookies for analytics. See our Privacy and Cookie Policy.